
Beacon is working with our client partner to build awareness and prescriptions for a different treatment that can help people with hemophilia A or B with inhibitors move on from bleeds. This campaign targets HCPs, patients, and caregivers to:
See how our launch of the first inhibitor bypassing agent approved in the US in over 20 years met the need of HCPs, patients, and caregivers for rapid, predictable, reliable control of bleeds.